Advertisement Pharmaceutical Business review - Page 332 of 5259 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 5, 2026

PrimeGen US and DT Cloud Star sign $1.5bn merger agreement

PrimeGen US and DT Cloud Star Acquisition have entered a definitive business combination agreement at an implied equity value of around $1.5bn.

Continue
PrimeGen US is preparing for a clinical trial to evaluate triple-activated MSCs for acute liver failure. Credit: Premreuthai / Shutterstock.com.
February 5, 2026

Everest Medicines and Micot partner on MT1013 commercialisation

The Phase III trial is enrolling around 424 SHPT patients on maintenance haemodialysis. Credit: sasirin pamai / Shutterstock.com.
February 3, 2026

SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal

The collaboration focuses on SanegeneBio’s RNAi platform, featuring new chemistries and delivery technologies for siRNA medicines. Credit: luchschenF / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Relay Therapeutics’ zovegalisib secures FDA BTD for advanced breast cancer
  2. CEPI and Samsung Biologics partner to boost global vaccine preparedness
  3. Aquestive receives FDA CRL for Anaphylm allergic reaction treatment
  4. CHMP grants positive opinion for J&J’s Akeega use
  5. CIRM unveils RAPID funding programme for rare diseases

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography